Support and Resistance Levels
Past performance
About Fredun Pharmaceuticals Ltd Fredun Pharmaceuticals (FPL), established in 1987, is a diversified pharmaceutical company engaged in manufacturing and marketing a wide range of formulations, diagnostics, and consultancy services. Initially founded as a private entity, it transitioned to a public limited company in 1994. The company supplies pharmaceutical formulations to over 42 countries and collaborates with numerous government entities to enhance healthcare systems globally. FPL operates a manufacturing facility in Palghar, Maharashtra, and has historically produced for prominent firms like Cipla and Merind.
FPL has continually expanded its product portfolio, including niche formulations, anti-diabetics, antiretrovirals, and anti-hypertensives. Recent developments include the introduction of new granulation departments and a variety of new products across different sectors. In 2023, FPL launched 19 products in its Cosmeceuticals OEM Division, 14 in pet pharmaceuticals, and 16 in pet nutritional supplements. The company's strategic focus on exports and new drug registrations in countries like Nepal, Tanzania, Uganda, and Sri Lanka highlights its optimism for future growth.